Richard L Edelson

Title: Richard L. Edelson: Innovator in Immunotherapy

Introduction

Richard L. Edelson is a prominent figure in the field of immunotherapy, based in Westport, CT. With an impressive portfolio of 23 patents, he has made significant contributions to the development of methods for treating diseases such as cancer. His innovative approaches focus on harnessing the power of the immune system to combat hyper-proliferative diseases.

Latest Patents

Among his recent patents, one includes a "Method for obtaining globally activated monocytes." This invention details methods for producing immuno-stimulatory autologous dendritic cells, which have the potential to be used in therapies for patients suffering from cancer. Another significant patent is titled "Methods for inducing the differentiation of blood monocytes into functional dendritic cells." This patent outlines a process where an extracorporeal quantity of a subject's blood is treated to produce a leukocyte concentrate, allowing for the generation of functional antigen presenting dendritic cells capable of enhancing immune responses.

Career Highlights

Edelson's career includes impactful roles at prestigious institutions such as Yale University and Therakos, Inc. His work has been instrumental in advancing the understanding and application of dendritic cell therapy, a cutting-edge approach in cancer treatment.

Collaborations

Throughout his career, Edelson has collaborated with renowned individuals in the field, including Francis P. Gasparro and Carole L. Berger. These partnerships have fostered innovation and have contributed to significant advancements in immunotherapy.

Conclusion

Richard L. Edelson stands out as a key innovator in the realm of immunotherapy, with a solid foundation in scientific research and practical applications. His ongoing contributions and collaborations continue to pave the way for new treatments that leverage the body’s immune system to fight cancer and other diseases.